139 related articles for article (PubMed ID: 16106049)
1. Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile.
van der Vleuten GM; van Tits LJ; den Heijer M; Lemmers H; Stalenhoef AF; de Graaf J
J Lipid Res; 2005 Nov; 46(11):2398-404. PubMed ID: 16106049
[TBL] [Abstract][Full Text] [Related]
2. Role of insulin resistance in familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
[TBL] [Abstract][Full Text] [Related]
3. Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.
van der Vleuten GM; Veerkamp MJ; van Tits LJ; Toenhake H; den Heijer M; Stalenhoef AF; de Graaf J
Atherosclerosis; 2005 Dec; 183(2):355-60. PubMed ID: 16285998
[TBL] [Abstract][Full Text] [Related]
4. Impact of obesity in primary hyperlipidemias.
Carmena R; Ascaso JF; Real JT
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
[TBL] [Abstract][Full Text] [Related]
5. High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.
de Graaf J; van der Vleuten GM; ter Avest E; Dallinga-Thie GM; Stalenhoef AF
J Clin Endocrinol Metab; 2007 Apr; 92(4):1269-75. PubMed ID: 17227806
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
7. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.
Allayee H; Dominguez KM; Aouizerat BE; Krauss RM; Rotter JI; Lu J; Cantor RM; de Bruin TW; Lusis AJ
J Lipid Res; 2000 Feb; 41(2):245-52. PubMed ID: 10681408
[TBL] [Abstract][Full Text] [Related]
9. Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia (FCH).
ter Avest E; Holewijn S; Bredie SJ; Stalenhoef AF; de Graaf J
Atherosclerosis; 2007 Mar; 191(1):220-6. PubMed ID: 16677651
[TBL] [Abstract][Full Text] [Related]
10. PAI-1 levels are related to insulin resistance and carotid atherosclerosis in subjects with familial combined hyperlipidemia.
Carratala A; Martinez-Hervas S; Rodriguez-Borja E; Benito E; Real JT; Saez GT; Carmena R; Ascaso JF
J Investig Med; 2018 Jan; 66(1):17-21. PubMed ID: 28822973
[TBL] [Abstract][Full Text] [Related]
11. Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.
López-Ruiz A; Jarabo MM; Martínez-Triguero ML; Morales-Suárez-Varela M; Solá E; Bañuls C; Casado M; Hernández-Mijares A
Lipids Health Dis; 2009 Mar; 8():12. PubMed ID: 19335919
[TBL] [Abstract][Full Text] [Related]
12. Increased thioredoxin levels are related to insulin resistance in familial combined hyperlipidaemia.
Martinez-Hervas S; Artero A; Martinez-Ibañez J; Tormos MC; Gonzalez-Navarro H; Priego A; Martinez-Valls JF; Saez GT; Real JT; Carmena R; Ascaso JF
Eur J Clin Invest; 2016 Jul; 46(7):636-42. PubMed ID: 27208733
[TBL] [Abstract][Full Text] [Related]
13. The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.
van der Vleuten GM; Kluijtmans LA; Hijmans A; Blom HJ; Stalenhoef AF; de Graaf J
Int J Obes (Lond); 2006 Jun; 30(6):892-8. PubMed ID: 16432543
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
[TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine in subjects with familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; den Heijer M; Blom HJ; Stalenhoef AF
Atherosclerosis; 2003 Jan; 166(1):111-7. PubMed ID: 12482557
[TBL] [Abstract][Full Text] [Related]
16. Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia.
Brouwers MC; van Greevenbroek MM; Vermeulen VM; van Lin JM; van der Kallen CJ; de Bruin TW
Clin Sci (Lond); 2007 Nov; 113(9):375-81. PubMed ID: 17564583
[TBL] [Abstract][Full Text] [Related]
17. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
[TBL] [Abstract][Full Text] [Related]
18. Relationship among adiponectin, insulin resistance and atherosclerosis in non-diabetic hypertensive patients and healthy adults.
Kou H; Deng J; Gao D; Song A; Han Z; Wei J; Jin X; Ma R; Zheng Q
Clin Exp Hypertens; 2018; 40(7):656-663. PubMed ID: 29336612
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.
Yamamoto Y; Hirose H; Saito I; Tomita M; Taniyama M; Matsubara K; Okazaki Y; Ishii T; Nishikai K; Saruta T
Clin Sci (Lond); 2002 Aug; 103(2):137-42. PubMed ID: 12149104
[TBL] [Abstract][Full Text] [Related]
20. [Familial combined hyperlipidemia - the most common genetic dyslipidemia in population and in patients with premature atherothrombotic cardiovascular disease].
Vaverková H; Karásek D
Vnitr Lek; 2018; 64(1):25-29. PubMed ID: 29498872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
